Incyte Corporation

09/27/2021 | Press release | Distributed by Public on 09/27/2021 04:35

Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases